Summary of the workshop on issues in risk assessment: quantitative methods for developmental toxicology.
This report summarizes the proceedings of a conference on quantitative methods for assessing the risks of developmental toxicants. The conference was planned by a subcommittee of the National Research Council's Committee on Risk Assessment Methodology in conjunction with staff from several federal agencies, including the U.S. Environmental Protection Agency, U.S. Food and Drug Administration, U.S. Consumer Products Safety Commission, and Health and Welfare Canada. Issues discussed at the workshop included computerized techniques for hazard identification, use of human and animal data for defining risks in a clinical setting, relationships between end points in developmental toxicity testing, reference dose calculations for developmental toxicology, analysis of quantitative dose-response data, mechanisms of developmental toxicity, physiologically based pharmacokinetic models, and structure-activity relationships. Although a formal consensus was not sought, many participants favored the evolution of quantitative techniques for developmental toxicology risk assessment, including the replacement of lowest observed adverse effect levels (LOAELs) and no observed adverse effect levels (NOAELs) with the benchmark dose methodology.
Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261.
D R
DR
Mattison
J D
JD
Sandler
D000818:Animals; D002170:Canada; D003257:Consumer Product Safety; D004305:Dose-Response Relationship, Drug; D004781:Environmental Exposure; D005544:Forecasting; D015386:Hazardous Substances / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity*; D006801:Humans; D008452:Maximum Allowable Concentration; D015233:Models, Statistical; D018570:Risk Assessment; D013329:Structure-Activity Relationship; D014481:United States; D014484:United States Environmental Protection Agency; D014486:United States Food and Drug Administration
D015386:Hazardous Substances